Ouyang Guoqing, Liu Qiang, Wu Yongrong, Liu Zhen, Lu Wuchang, Li Shuai, Pan Guangdong, Chen Xiang
Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou, China.
Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Cancer. 2021 Jul 1;127(13):2238-2250. doi: 10.1002/cncr.33476. Epub 2021 Mar 22.
The global burden of gallbladder and biliary tract cancer (GBTC) is increasing. A comprehensive evaluation of the burden is crucial to improve strategies for GBTC prevention and treatment.
The incidence rates, mortality, and disability-adjusted life years (DALYs) of GBTC from 1990 to 2017 were extracted from the Global Burden of Diseases Study (GBD) 2017. Estimated annual percent changes (EAPCs) were calculated to quantify GBTC trends during the study period.
Globally, there were 210,878 new cases, 173,974 deaths, and 3,483,046 DALYs because of GBTC in 2017. GBTC incidence increased by 76%, mortality increased by 65%, and DALYs increased by 52% from 1990 to 2017. In addition, relatively higher Socio-Demographic Index regions had greater incidence and death rates but greatly decreased age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR). At the national level, Chile had the highest ASIR (10.38 per 100,000 population) and the highest ASDR (10.43 per 100,000 population) in 2017. The largest increases in ASIR (EAPC, 3.38) and ASDR (EAPC, 3.39) were observed in Georgia. Nonlinear associations were observed between the ASDR, the Socio-Demographic Index, and DALYs at the 21 GBD regional levels and at the national level. The proportions of GBTC age-standardized deaths and DALYs attributable to high body mass index were 15.4% and 16%, respectively.
GBTC remains a major health burden worldwide. These findings are expected to prompt policymakers to establish a cost-effective method for the early diagnosis, prevention, and treatment of GBTC, reducing its modifiable risk factors and reversing its increasing trends.
Although the rates of age-standardized incidence, death, and disability-adjusted life-years for gallbladder and biliary tract cancer decreased from 1990 to 2017, the numbers of these measures increased. Nonlinear associations existed between the age-standardized death rate, the Socio-Demographic Index, and disability-adjusted life-years at the 21 regional and national levels in the Global Burden of Disease Study.
全球胆囊和胆道癌(GBTC)负担正在增加。对该负担进行全面评估对于改进GBTC预防和治疗策略至关重要。
从《2017年全球疾病负担研究》(GBD 2017)中提取1990年至2017年GBTC的发病率、死亡率和伤残调整生命年(DALY)。计算估计年度百分比变化(EAPC)以量化研究期间GBTC的趋势。
2017年全球范围内,因GBTC出现210,878例新发病例、173,974例死亡以及3,483,046个DALY。从1990年到2017年,GBTC发病率增加了76%,死亡率增加了65%,DALY增加了52%。此外,社会人口指数相对较高的地区发病率和死亡率更高,但年龄标准化发病率(ASIR)和年龄标准化死亡率(ASDR)大幅下降。在国家层面,2017年智利的ASIR最高(每10万人口中10.38例),ASDR最高(每10万人口中10.43例)。在格鲁吉亚观察到ASIR(EAPC,3.38)和ASDR(EAPC,3.39)的增幅最大。在21个GBD区域层面和国家层面,观察到ASDR、社会人口指数和DALY之间存在非线性关联。GBTC年龄标准化死亡和DALY中归因于高体重指数的比例分别为15.4%和16%。
GBTC仍然是全球主要的健康负担。这些发现有望促使政策制定者建立一种具有成本效益的GBTC早期诊断、预防和治疗方法,减少其可改变的风险因素并扭转其上升趋势。
尽管从1990年到2017年胆囊和胆道癌的年龄标准化发病率、死亡率以及伤残调整生命年率有所下降,但这些指标的数量却有所增加。在《全球疾病负担研究》的21个区域和国家层面,年龄标准化死亡率、社会人口指数和伤残调整生命年之间存在非线性关联。